Please login to the form below
Grail
This page shows the latest Grail news and features for those working in and with pharma, biotech and healthcare.
NHS set to pilot GRAIL’s wide-ranging cancer blood test
Previous study indicates test can detect over 50 cancer types. The UK’s National Health Service (NHS) has signed a deal with healthcare company GRAIL to pilot its novel cancer blood ... GRAIL is hoping to commercially launch the test in the US in 2021,
Latest news
-
Awesome abstraction
Some even compare it to the physicists’ Holy Grail and describe it as a ‘Grand Unifying Theory’ of how industries and firms change.
-
Grail’s multi-cancer blood test gets FDA breakthrough status
Unlike existing tests, Grail's technology is based on vast amounts of tumour genome data which it obtains through high-intensity gene sequencing. ... We hope our test may offer a chance to address these challenges,” said Grail's CEO, Jennifer Cook.
-
Cell therapy disruptor Mogrify gains $3.7m in funding and a new leader
Commenting on the platform and his new appointment, Disley said: “Direct reprograming between mature human cell types is a holy grail of regenerative medicine and pharmaceutical applications.
-
Beneluxa: the future of European market access?
yet. The ‘holy grail’ would of course be to grant rapid access to patients to effective new treatments, while supporting an innovative industry and also operating a sustainable healthcare system – however
-
Grail to initiate largest ever UK cancer screening study
Will start testing on 50, 000 people in early 2019. Genomics company Grail has revealed ambitious plans to deploy its investigational cancer detecting blood test into 50, 000 people in what ... Anne-Renee Hartman. Hartman also announced that Grail will
More from news
Approximately 2 fully matching, plus 25 partially matching documents found.
Latest Intelligence
-
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
At Purple, we have found new ways to work ourselves and to engage with clients and, although a live event is still a Holy Grail, we have to accept that life
-
All change – how untangling human behaviour can encourage better health
It is a Holy Grail of healthcare with legions crusading to lay their hands on the keys to guide populations away from poor health decisions and loose medical adherence as financial
-
Product launches: making the most of your one shot
Bringing it home again: making launch excellence standard. Elon Musk recently lauded reusable rockets as the ‘holy grail’ of space travel.
-
Combining hard technology with human skills
That’s the definition of omnichannel excellence – and it’s the holy grail in B2B.
-
Turning learning into action: the challenge of behaviour change
But does it work? Measuring the real-world impact of communication and education programmes on behaviour has, in recent years, become the holy grail for agencies and pharma clients.
More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest appointments
-
Parkinson's UK appoints Arthur Roach as research director
t cracked the Holy Grail of Parkinson's research - a cure.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Why you should feel optimistic about the future of healthcare
It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic. Optimists have had a difficult time over the past year. However, there are many reasons to be hopeful about
-
How to keep your weight under control during lockdown
That is the Holy Grail of the dieting world and if anyone ever did find it then a lot of people in the weight loss industry would be out a job.
-
Curb your enthusiasm (if you want to impress)
his credibility." When interviewed about his discovery, DePalma said, "It's like finding the Holy Grail clutched in the bony fingers of Jimmy Hoffa, sitting on top of the Lost Ark" –
-
Turning learning into action: The challenge of behaviour change
But does it work? Measuring the real-world impact of communication and education programmes on behaviour has, in recent years, become the holy grail for agencies and pharma clients.
-
Hunt vs Hawking: We'll call it a draw
He just literally doesn't know when he's beaten. Like the Black Knight in Monty Python &the Holy Grail, balancing on bleeding stumps with all his limbs hacked off, declaring:
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
